+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 51Years
All Genders
ID07227584

Chemotherapy Treatment Evaluation for Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in Adolescents and Young Adults

Led by Dana-Farber Cancer Institute · Updated on 2026-08-17

67

Participants Needed

1

Research Sites

260 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating a chemotherapy regimen for adolescents and young adults with newly diagnosed Philadelphia chromosome-negative acute lymphoblastic leukemia ALL. This Phase 2, single-arm study aims to better understand the safety and effectiveness of this treatment in this specific group. The study drugs include several chemotherapy agents and immunotherapy, all FDA-approved but studied here as a combined regimen. The treatment involves multiple phases such as Steroid Prophase, Induction IA and IB, several Blinatumomab cycles, and Consolidation and Continuation phases. These phases include administration of various drugs like dexamethasone, vincristine, pegaspargase, doxorubicin, cyclophosphamide, cytarabine, mercaptopurine, methotrexate, etoposide, and blinatumomab. Treatments are given in cycles lasting from 3 to 42 days, with intrathecal chemotherapy injections included. After about 2 years of treatment, participants will have an end of treatment visit followed by an 8-year follow-up period. Participants will undergo screening, in-clinic visits, and various tests including blood, urine, saliva tests, X-rays, ECGs, echocardiograms, DEXA scans, and bone marrow biopsiesaspirations. Researchers will monitor treatment completion, treatment-related mortality, toxicity rates, remission rates, measurable residual disease, survival outcomes, and transplantation rates. The entire participation is expected to last about 10 years, with close monitoring of adverse events and long-term outcomes.

CONDITIONS

Brief Title

ALL Backbone in AYAs

Research Team

M

Marlise R Luskin, MD, MSCE

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here